Target Selection for CAR-T Therapy

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-019-0758-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Teaming Up for CAR-T Cell Therapy

Haematologica
Hematology
2019English

MUC1 as a Target for CAR-T Therapy in Head and Neck Squamous Cell Carinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Eligibility for Car T-Cell Therapy: An Analysis of Selection Criteria and Survival Outcomes in Chemorefractory DLBCL

American Journal of Hematology
Hematology
2019English

Next Frontiers in CAR T-Cell Therapy

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Accelerating CAR Therapy in CLL: The Development and Challenges of CAR T Cell Therapy for Chronic Lymphocytic Leukemia

American Journal of Hematology
Hematology
2019English

CAR-T Based Immuno-Therapy: New Hope for Cancer Patients

Journal of Tumor Medicine & Prevention
2017English

“What's in a Name?” CAR-T Gene Therapy

Hastings Center Report
Health PolicyPhilosophyLegal AspectsHealthEthicsIssues
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy